GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (LTS:0QIU) » Definitions » Net Margin %

Novo Nordisk A/S (LTS:0QIU) Net Margin %

: 33.35% (As of Dec. 2023)
View and export this data going back to 2009. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Novo Nordisk A/S's Net Income for the three months ended in Dec. 2023 was kr21,963 Mil. Novo Nordisk A/S's Revenue for the three months ended in Dec. 2023 was kr65,863 Mil. Therefore, Novo Nordisk A/S's net margin for the quarter that ended in Dec. 2023 was 33.35%.

The historical rank and industry rank for Novo Nordisk A/S's Net Margin % or its related term are showing as below:

LTS:0QIU' s Net Margin % Range Over the Past 10 Years
Min: 29.82   Med: 33.56   Max: 36.03
Current: 36.03


LTS:0QIU's Net Margin % is ranked better than
95.42% of 1026 companies
in the Biotechnology industry
Industry Median: -163.08 vs LTS:0QIU: 36.03

Novo Nordisk A/S Net Margin % Historical Data

The historical data trend for Novo Nordisk A/S's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.92 33.19 33.92 31.38 36.03

Novo Nordisk A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.26 37.13 35.78 38.27 33.35

Competitive Comparison

For the Biotechnology subindustry, Novo Nordisk A/S's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk A/S Net Margin % Distribution

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's Net Margin % distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's Net Margin % falls into.



Novo Nordisk A/S Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Novo Nordisk A/S's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=83683/232261
=36.03 %

Novo Nordisk A/S's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=21963/65863
=33.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novo Nordisk A/S  (LTS:0QIU) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Novo Nordisk A/S Net Margin % Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk A/S (LTS:0QIU) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S (LTS:0QIU) Headlines

No Headlines